AIN457

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica

SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis

An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)

A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis

38 Week Extension Study to CAIN457C2303

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Phase III Study in Refractory Behcet's Disease

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis